Sakura Bio
Allogeneic Cell Therapy Platform
Active
Pre-Seed
Startup
Jerusalem
Founded 2022-10
Sakura Bio has developed an off-the-shelf, naïve PBMC-derived allogeneic T-cell therapy to fight cancer — in particular, acute myeloid leukemia. The company's platform focuses on creating super-activated killer cells, an allogenic T-cell therapy produced via a simple, relatively short manipulation of naïve PBMCs. Sakura Bio's lead product, Super Activated K…
SectorHealth Tech & Life Sciences
StagePre-Seed
Total raised$1.7M
Employees5
Founded2022-10
HQJerusalem
Confidence88
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareLaboratories